Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRACP-5b as a Novel Biomarker for the Diagnosis and Monitoring of Patients With Giant Cell Tumor of Bone

NCT07609277 is registered in ClinicalTrials.gov with St. Anne's University Hospital Brno, Czech Republic as lead sponsor.

NCT NCT07609277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07609277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRACP-5b as a Novel Biomarker for the Diagnosis and Monitoring of Patients With Giant Cell Tumor of Bone
Lead sponsor
St. Anne's University Hospital Brno, Czech Republic
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
May 31, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease surveillance and monitoring, giant cell tumor of bone, tartrate-resistant acid phosphatase 5b, tracp-5b